Pune, Nov. 11, 2022 (GLOBE NEWSWIRE) -- “Glоbаl Metformin Hydrochloride Маrkеt” іѕ thе tіtlе оf а rесеntlу рublіѕhеd rероrt bу JCMR market research. Тhе rеѕеаrсh ѕtudу іnvоlvеd ехреrt оріnіоn and with ...

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "Metformin Hydrochloride (CAS 1115-70-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added ...

Whitehouse Station, NJ - Merck announced on February 2, 2012 that the US Food and Drug Administration (FDA) has approved Janumet XR (sitagliptin and extended-release metformin hydrochloride) tablets ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...

Details concerning the Metformin Hydrochloride (ER) combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN, N.J, ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Metformin (Metformin Hydrochloride) is an oral ...

The European Commission has approved JENTADUETO for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally ...

The Metformin Hydrochloride API Market report is a look of first-hand information, qualitative and quantitative assessment by market analysts, inputs from industry experts and industry participants ...

AstraZeneca and Bristol-Myers Squibb today announced that Xigduo™ (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) has been granted Marketing Authorisation by the ...

A recall has been ordered for a high-profile diabetes drug after producers discovered it contained alarmingly high levels of a cancer-causing impurity. Marksans Pharma Limited has recalled metformin ...